Abstract 203 Table 1
Outcome
Treated with Benznidazole or Nifurtimox (n=
7)
No Treatment (n=
6)
P-value
Reactivation
100.0%
50.0%
0.070
Symptomatic Disease
14.3%
0.0%
1.000
1-Year Survival
100.0%
66.7%
0.110
5-Year Survival
100.0%
50.0%
0.040